1. Abbas
A. K.
Lichtman
A. H.
& Pillai
S. (2020). Cellular and Molecular Immunology (10th ed.). Elsevier.
For Lupus (Type III): Chapter 19
"Diseases Caused by Immune Responses: Hypersensitivity and Autoimmunity
" Section on "Immune Complex-Mediated Diseases (Type III Hypersensitivity)
" states
"Systemic lupus erythematosus (SLE) is the prototypic systemic immune complex–mediated disease."
For Graves disease and Myasthenia gravis (Type II): Chapter 19
Section on "Antibody-Mediated Diseases (Type II Hypersensitivity)
" lists Graves' disease and myasthenia gravis as examples of diseases caused by antibodies against cell surface receptors.
For Hashimoto's thyroiditis (Type IV): Chapter 19
Section on "T Lymphocyte-Mediated Diseases (Type IV Hypersensitivity)
" describes Hashimoto's thyroiditis as an autoimmune disease resulting from T-cell mediated destruction of thyroid epithelial cells.
2. Justiz Vaillant
A. A.
& Zulfiqar
H. (2023). Hypersensitivity Reactions. In StatPearls. StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK560561/
Table 1
"Gell and Coombs Classification of Hypersensitivity Reactions
" explicitly lists Systemic Lupus Erythematosus under Type III
Allergic Rhinitis under Type I
Graves' Disease and Myasthenia Gravis under Type II
and Hashimoto's Thyroiditis under Type IV.
3. Stanford University School of Medicine. (n.d.). Immunology Course (IMM 205/206) Lecture Notes: Hypersensitivity Reactions.
In lectures covering the Gell and Coombs classification
Lupus is consistently presented as the archetypal Type III reaction due to immune complex deposition in tissues like the glomeruli. Graves' disease and Myasthenia gravis are used as primary examples of Type II receptor-targeting antibody-mediated disease.